FOUNDERS FINANCIAL SECURITIES LLC

Broker-Dealer

Position in GSK — GSK plc

CIK 1342396 TOWSON, MD

Position in GSK

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,136,098

-$30,894 QoQ

Shares Held

21,673

+2.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#336

of 1,033 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FOUNDERS FINANCIAL SECURITIES LLC holds $21,446,689 across 11 Drug Manufacturers - General names. GSK ranks #7 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	23,408	$5,944,929
2	AMGN	Amgen Inc	8,037	$2,910,358
3	MRK	Merck & Co., Inc.	19,290	$2,478,765
4	ABBV	AbbVie Inc.	9,802	$2,466,575
5	AZN	Astrazeneca PLC	12,714	$2,410,828
6	LLY	ELI LILLY & Co	1,169	$1,402,133
7	GSK	GSK plc This page	21,673	$1,136,098
8	GILD	Gilead Sciences, Inc.	8,321	$1,051,275

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,136,098	21,673	+2.5%	Shares	Defined	2026-07-31
2026-03-31	$1,166,992	21,145	+2.9%	Shares	Defined	2026-04-17
2025-12-31	$1,007,281	20,540	+8.2%	Shares	Sole	2026-02-10
2025-09-30	$819,176	18,980	+4.9%	Shares	Sole	2025-10-15
2025-06-30	$694,540	18,087	+4.4%	Shares	Sole	2025-08-06
2025-03-31	$671,247	17,327	-0.9%	Shares	Sole	2025-05-12
2024-12-31	$591,376	17,486	+3.0%	Shares	Sole	2025-02-10
2024-09-30	$693,856	16,973	-4.4%	Shares	Sole	2024-11-12
2024-06-30	$683,760	17,760	+3.1%	Shares	Sole	2024-08-02
2024-03-31	$738,135	17,218	+21.2%	Shares	Sole	2024-04-17
2020-09-30	$524,668	14,212	-12.0%	Shares	Sole	2020-11-16
2020-06-30	$645,790	16,142	+7.4%	Shares	Sole	2020-08-12
2020-03-31	$558,515	15,029	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.